The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

About a third of small businesses discontinue their health insurance coverage from one year to the next, new research from ...

Pfizer is playing catch-up in the crowded field of obesity medicines, but it hoped to compete with a daily pill alternative to currently available injectable GLP-1 products. Instead, Pfizer is ...

As we navigate through 2025, the American healthcare system stands at a critical juncture. The demographic shifts that have been gradually unfolding are now accelerating, creating challenges that ...

The pairing of two Bristol Myers Squibb immunotherapies is now permitted for the first-line treatment of two types of gastrointestinal cancers, after regulatory decisions handed out this past week ...

Cofertility, a Los Angeles-based startup aimed at making family-building more equitable and accessible, closed a $7.25 million Series A funding round this month. The financing round — which ...

Some of the most recently available data brings welcome news in the nationwide fight against the opioid epidemic. After many months of increasing overdose deaths in the wake of the Covid pandemic ...

There has been a noticeable shift in the tone across the US over the past several years, escalating in recent months. An intensifying pattern of pervasive anxiety has surfaced among individuals ...

Healthcare staff members are finding Artera’s AI copilots helpful and easy to use after six months of real-world deployment. Artera, a digital health software company based in Santa Barbara ...

The 2024 Medicare Advantage Final Rule changed inpatient coverage, requiring healthcare providers to reevaluate their patient strategies. Unlike traditional Medicare Part A, Medicare Advantage (MA ...